• Login
    View Item 
    •   Home
    • The Christie Research Publications Repository
    • All Christie Publications
    • View Item
    •   Home
    • The Christie Research Publications Repository
    • All Christie Publications
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

    All of ChristieCommunitiesTitleAuthorsIssue DateSubmit DateSubjectsThis CollectionTitleAuthorsIssue DateSubmit DateSubjects

    My Account

    LoginRegister

    Local Links

    The Christie WebsiteChristie Library and Knowledge Service

    Statistics

    Display statistics

    Results of a UK real world study of polatuzumab vedotin, bendamustine, and rituximab for relapsed/refractory large B-cell lymphoma

    • CSV
    • RefMan
    • EndNote
    • BibTex
    • RefWorks
    Thumbnail
    Name:
    Results Northend.pdf
    Size:
    1.276Mb
    Format:
    PDF
    Description:
    From UNPAYWALL
    Download
    Authors
    Northend, M.
    Wilson, W.
    Osborne, W.
    Fox, C. P.
    Davies, A. J.
    El-Sharkawi, D.
    Phillips, E. H.
    Sim, H. W.
    Sadullah, S.
    Shah, N.
    Peng, Y. Y.
    Qureshi, I.
    Addada, J.
    Mora, R. F.
    Phillips, N.
    Kuhnl, A.
    Davies, E.
    Wrench, D. J.
    McKay, P.
    Karpha, I.
    Cowley, A.
    Karim, R.
    Challenor, S.
    Singh, V.
    Burton, C.
    Auer, R.
    Williams, C.
    Cunningham, J.
    Broom, A.
    Arasaretnam, A.
    Roddie, C.
    Menne, T.
    Townsend, W. M.
    Show allShow less
    Affiliation
    Cancer Research UK & UCL Cancer Trials Centre, United Kingdom. Cancer Research UK & UCL Cancer Trials Centre, London, United Kingdom. Newcastle upon Tyne Hospitals NHS Foundation trust, Newcastle upon Tyne, United Kingdom. Nottingham University Hospitals, Nottingham, United Kingdom. University of Southampton, Southampton, United Kingdom. Royal Marsden Hospital, Sutton, United Kingdom. Division of Cancer Sciences, University of Manchester and Manchester Cancer Research Centre, Manchester, United Kingdom. London North West Healthcare NHS Trust, Middlesex, United Kingdom. James Paget University Hospitals NHS Foundation Trust, Great Yarmouth, United Kingdom. Norfolk and Norwich University Hospital, Norwich, United Kingdom. St George's University Hospitals NHS Foundation Trust, London, United Kingdom. University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom. Royal Derby Hospital, Derby, United Kingdom. Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom. University Hospitals of the North Midlands NHS Trust, Stoke-on-Trent, United Kingdom. King's College Hospital NHS Foundation Trust, London, United Kingdom. Manchester University NHS Foundation Trust, Manchester, United Kingdom. Guy's and St.Thomas' NHS Foundation Trust, London, United Kingdom. Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom. The Clatterbridge Cancer Centre, Liverpool, United Kingdom. East Sussex Healthcare NHS Trust, Eastbourne, United Kingdom. Dorset County Hospital NHS Foundation Trust, Dorchester, United Kingdom. Royal Cornwall Hospital Trust, Truro, United Kingdom. Aintree University Hospital, Liverpool, United Kingdom. St James's University Hospital, Leeds, United Kingdom. Bart's Health NHS Trust, United Kingdom. Northumbria Healthcare NHS Foundation Trust, Hexham, United Kingdom. Western General Hospital, Edinburgh, United Kingdom. University Hospitals Sussex NHS Trust, Brighton, United Kingdom. UCL, London, United Kingdom. University College London Hospitals, London, United Kingdom.
    Issue Date
    2022
    
    Metadata
    Show full item record
    Citation
    Northend M, Wilson W, Osborne W, Fox CP, Davies AJ, El-Sharkawi D, et al. Results of a UK real world study of polatuzumab vedotin, bendamustine, and rituximab for relapsed/refractory large B-cell lymphoma. Blood Advances. American Society of Hematology; 2022.
    Journal
    Blood Advances
    URI
    http://hdl.handle.net/10541/625079
    DOI
    10.1182/bloodadvances.2021005953
    PubMed ID
    35020818
    Additional Links
    https://dx.doi.org/10.1182/bloodadvances.2021005953
    Type
    Other
    Language
    en
    ae974a485f413a2113503eed53cd6c53
    10.1182/bloodadvances.2021005953
    Scopus Count
    Collections
    All Christie Publications

    entitlement

    Related articles

    • Polatuzumab vedotin to treat relapsed or refractory diffuse large B-cell lymphoma, in combination with bendamustine plus rituximab.
    • Authors: Amaya ML, Jimeno A, Kamdar M
    • Issue date: 2020 Apr
    • [Efficacy and safety of Polatuzumab Vedotin in combination with rituximab plus bendamustine in patients with relapsed/refractory diffuse large B-cell lymphoma: a single center analysis].
    • Authors: Kong FC, Yu M, Zhou YL, Wang SX, Li F
    • Issue date: 2022 Jan 14
    • Polatuzumab vedotin, rituximab, and bendamustine combination in relapsed or refractory diffuse large B-cell lymphoma: a real-world data from Turkey.
    • Authors: Dal MS, Ulu BU, Uzay A, Akay OM, Beşışık S, Yenerel MN, Çelik S, Kaynar L, Yücel OK, Deveci B, Sönmez M, Mehtap Ö, Beköz HS, Sunu C, Salim O, Ulaş T, Kartı S, Altuntaş F, Ferhanoğlu B, Tuğlular TF
    • Issue date: 2023 Jan
    • Polatuzumab vedotin plus bendamustine and rituximab in patients with relapsed/refractory diffuse large B-cell lymphoma in the real world.
    • Authors: Vodicka P, Benesova K, Janikova A, Prochazka V, Belada D, Mocikova H, Steinerova K, Duras J, Karban J, Hanackova V, Sykorova A, Obr A, Trneny M
    • Issue date: 2022 Aug
    • Polatuzumab vedotin plus bendamustine and rituximab in relapsed/refractory DLBCL: survival update and new extension cohort data.
    • Authors: Sehn LH, Hertzberg M, Opat S, Herrera AF, Assouline S, Flowers CR, Kim TM, McMillan A, Ozcan M, Safar V, Salles G, Ku G, Hirata J, Chang YM, Musick L, Matasar MJ
    • Issue date: 2022 Jan 25
    DSpace software (copyright © 2002 - 2023)  DuraSpace
    Quick Guide | Contact Us
    Open Repository is a service operated by 
    Atmire NV
     

    Export search results

    The export option will allow you to export the current search results of the entered query to a file. Different formats are available for download. To export the items, click on the button corresponding with the preferred download format.

    By default, clicking on the export buttons will result in a download of the allowed maximum amount of items.

    To select a subset of the search results, click "Selective Export" button and make a selection of the items you want to export. The amount of items that can be exported at once is similarly restricted as the full export.

    After making a selection, click one of the export format buttons. The amount of items that will be exported is indicated in the bubble next to export format.